Designs and tests gene-based treatments that target inherited eye conditions to restore or protect vision.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Atsena Therapeutics is a clinical-stage gene therapy company that develops innovative genetic medicines aimed at preventing or reversing vision loss caused by inherited retinal diseases. The company advances therapeutic programs powered by engineered viral vector technology to create treatments that address the underlying genetic causes of blindness and support improved visual outcomes for patients.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Abingworth
Hatteras Venture Partners
Lightstone Ventures
Sofinnova Investments
Bain Capital
Foundation Fighting Blindness
University of Florida Research Foundation
Osage University Partners
PBM Capital Group
Wellington Management Company
Atsena Therapeutics Valuations & Financials
View real-time NPM data on Atsena Therapeutics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Atsena Therapeutics
FAQ
We have answers
Atsena Therapeutics stock does not trade on public stock exchanges. Atsena Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Atsena Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Atsena Therapeutics Stock does not trade on public stock exchanges. In order to sell Atsena Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Atsena Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Atsena Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Atsena Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Atsena Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Atsena Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Atsena Therapeutics is a private company and has not had an IPO. There is currently no Atsena Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Atsena Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
